Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - pimecrolimusum - crème - pimecrolimusum 10 mg, natrii hydroxidum, acidum citricum, natrii cetylo- et stearylosulfas, glyceroli monostearas 40-55, alcohol cetylicus 40 mg, alcohol stearylicus 40 mg, propylenglycolum 50 mg, alcohol oleicus, triglycerida media, aqua purificata, alcohol benzylicus 10 mg, ad unguentum pro 1 g. - dermatite atopique - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés - everolimusum 0,5 mg, lactosum monohydricum 4.45 mg, hypromellosum, magnésium stearas, crospovidonum, lactosum 74.38 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés - everolimusum 0,75 mg, lactosum monohydricum 6.68 mg, hypromellosum, magnésium stearas, crospovidonum, lactosum 111.56 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés - everolimusum 0,25 mg, lactosum monohydricum 2.23 mg, hypromellosum, magnésium stearas, crospovidonum, lactosum de 51,1 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés - everolimusum 1 mg, lactosum monohydricum 8,9 mg, hypromellosum, magnésium stearas, crospovidonum, lactosum 148.75 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés dispersibles - everolimusum 0,25 mg, lactosum monohydricum 2.23 mg, hypromellosum, magnésium stearas, crospovidonum, lactosum 178.75 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - comprimés dispersibles - everolimusum 0,1 mg, lactosum monohydricum 0,89 mg, hypromellosum, magnésium stearas, de la silice colloidalis anhydrica, crospovidonum, lactosum 71.5 mg, e 321, pro compresso. - prophylaxie de organabstossungen - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astellas pharma ag - tacrolimusum - retardkapseln - tacrolimusum 0.5 mg, hypromellosum, ethylcellulosum, lactosum monohydricum 53.64 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (rubrum), e 172 (flavum), natrii laurilsulfas corresp. natrium 200 ppm, drucktinte: lacca, lecithinum ex soja, simeticonum, hydroxypropylcellulosum, e 172 (rubrum), pro capsula. - immunsuppressivum - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astellas pharma ag - tacrolimusum - retardkapseln - tacrolimusum 1 mg, hypromellosum, ethylcellulosum, lactosum monohydricum 107.28 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), natrii laurilsulfas corresp. natrium 200 ppm, drucktinte: lacca, lecithinum ex soja, simeticonum, hydroxypropylcellulosum, e 172 (rubrum), pro capsula. - immunsuppressivum - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astellas pharma ag - tacrolimusum - retardkapseln - tacrolimusum 5 mg, hypromellosum, ethylcellulosum, lactosum monohydricum 536.4 mg, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), natrii laurilsulfas corresp. natrium 200 ppm, drucktinte: lacca, lecithinum ex soja, simeticonum, hydroxypropylcellulosum, e 172 (rubrum), pro capsula. - immunsuppressivum - synthetika